ADVERTISEMENT

Pain Management Pharmacy Board Certification Review and Recertification Activities

APhA, AAPP, ASCP, and SPPCP are collaborating to offer board prep and recertification education for the pain management pharmacy credential. APhA’s offerings include education from the APhA Annual Meeting & Exposition that are designed for both review and recertification on trending topics in pain management.

Board prep materials
Recertification materials
Trending Topics in Pain Management: 2026 Package
  • Sessions from APhA2026 in Los Angeles, recorded for your viewing wherever, whenever
  • The package contains 5 hours of BCPMP exam content prep
  • Topics include migraine management, non-opioids for pain management, overdose management, pharmacogenomics, and palliative care
  • Member pricing: $119 ($24/credit), Nonmember pricing: $169 ($34/credit)

Enroll now  

Trending Topics in Pain Management: 2026 Package
  • Sessions from APhA2026 in Los Angeles, recorded for your viewing wherever, whenever
  • The package contains 5 hours of BCPMP recertification credit
  • Topics include migraine management, non-opioids for pain management, overdose management, pharmacogenomics, and palliative care
  • Member pricing: $119 ($24/credit), Nonmember pricing: $169 ($34/credit)

Enroll now  

Want more education? Check out our Partner’s offerings!

American Association of Psychiatric Pharmacists (AAPP)

Annually, AAPP will offer dual BCPP and BCPMP recertification credit for select presentations within the Clinical Application Series and/or Summit products. Periodically, the From Theory to Practice Case Series product may also be awarded dual BCPP and BCPMP recertification credit.

Learn More  

BCPMP logo

The American Pharmacists Association in collaboration with the Society of Pain and Palliative Care Pharmacists, the American Society of Consultant Pharmacists, and the American Association of Psychiatric Pharmacists is approved as a professional development provider for the Board-Certified Pain Management Pharmacists specialty by the Board of Pharmacy Specialties.

ADVERTISEMENT